These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 21305609)

  • 21. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
    Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
    Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of RANKL-mediated osteoclast differentiation by selective TRAF6 decoy peptides.
    Poblenz AT; Jacoby JJ; Singh S; Darnay BG
    Biochem Biophys Res Commun; 2007 Aug; 359(3):510-5. PubMed ID: 17544369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smad protein mediated transforming growth factor beta1 induction of apoptosis in the MDPC-23 odontoblast-like cell line.
    He WX; Niu ZY; Zhao SL; Smith AJ
    Arch Oral Biol; 2005 Nov; 50(11):929-36. PubMed ID: 16183370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
    Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
    Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
    He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
    Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors.
    Itoh K; Udagawa N; Matsuzaki K; Takami M; Amano H; Shinki T; Ueno Y; Takahashi N; Suda T
    J Bone Miner Res; 2000 Sep; 15(9):1766-75. PubMed ID: 10976996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Segregation of TRAF6-mediated signaling pathways clarifies its role in osteoclastogenesis.
    Kobayashi N; Kadono Y; Naito A; Matsumoto K; Yamamoto T; Tanaka S; Inoue J
    EMBO J; 2001 Mar; 20(6):1271-80. PubMed ID: 11250893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A dual role of TGF-β in human osteoclast differentiation mediated by Smad1 versus Smad3 signaling.
    Lee B; Oh Y; Jo S; Kim TH; Ji JD
    Immunol Lett; 2019 Feb; 206():33-40. PubMed ID: 30543834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coculture of osteoclast precursors with rheumatoid synovial fibroblasts induces osteoclastogenesis via transforming growth factor beta-mediated down-regulation of osteoprotegerin.
    Hase H; Kanno Y; Kojima H; Sakurai D; Kobata T
    Arthritis Rheum; 2008 Nov; 58(11):3356-65. PubMed ID: 18975335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-myc is required for osteoclast differentiation.
    Battaglino R; Kim D; Fu J; Vaage B; Fu XY; Stashenko P
    J Bone Miner Res; 2002 May; 17(5):763-73. PubMed ID: 12009006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells.
    Pang M; Martinez AF; Fernandez I; Balkan W; Troen BR
    Gene; 2007 Nov; 403(1-2):151-8. PubMed ID: 17897792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.
    Takimoto T; Wakabayashi Y; Sekiya T; Inoue N; Morita R; Ichiyama K; Takahashi R; Asakawa M; Muto G; Mori T; Hasegawa E; Saika S; Hara T; Nomura M; Yoshimura A
    J Immunol; 2010 Jul; 185(2):842-55. PubMed ID: 20548029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of RANKL-induced osteoclastogenesis by RING finger protein RNF114.
    Lin B; Ke Q; Leaman DW; Goel V; Agarwal A
    J Orthop Res; 2018 Jan; 36(1):159-166. PubMed ID: 28708287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCL3 regulates RANKL-induced osteoclastogenesis by interacting with TRAF6 in bone marrow-derived macrophages.
    Wang K; Li S; Gao Y; Feng X; Liu W; Luo R; Song Y; Ji Tu ; Liu Y; Yang C
    Bone; 2018 Sep; 114():257-267. PubMed ID: 29933112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-assembled RANK induces osteoclastogenesis ligand-independently.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 Nov; 20(11):2053-60. PubMed ID: 16234979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling.
    He W; Cronstein BN
    Purinergic Signal; 2012 Jun; 8(2):327-37. PubMed ID: 22311477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner.
    Bai S; Kitaura H; Zhao H; Chen J; Müller JM; Schüle R; Darnay B; Novack DV; Ross FP; Teitelbaum SL
    J Clin Invest; 2005 Oct; 115(10):2742-51. PubMed ID: 16184196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RANKL cytokine enhances TNF-induced osteoclastogenesis independently of TNF receptor associated factor (TRAF) 6 by degrading TRAF3 in osteoclast precursors.
    Yao Z; Lei W; Duan R; Li Y; Luo L; Boyce BF
    J Biol Chem; 2017 Jun; 292(24):10169-10179. PubMed ID: 28438834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis.
    Gohda J; Akiyama T; Koga T; Takayanagi H; Tanaka S; Inoue J
    EMBO J; 2005 Feb; 24(4):790-9. PubMed ID: 15678102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors.
    Lin J; Lee D; Choi Y; Lee SY
    Sci Signal; 2015 Jun; 8(379):ra54. PubMed ID: 26038599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.